PureTechHealthtoPresentattheJefferies2016HealthcareConferenceinLondonBoston,Massachusetts,November2,2016–PureTechHealthplc(“PureTech”orthe“Company”,LSE:PRTC),across-disciplinarybiotechcompanydeveloping21stcenturymedicines,todayannouncedthatDaphneZohar,PureTechHealth’sChiefExecutiveOfficer,willpresentattheJefferies2016LondonHealthcareConferenceonWednesday,November16,at4:00pmGMT.Awebcastofthepresentationwillbeavailableathttp://puretechhealth.com/investors.phpundertheReportsandPresentationstab.

AboutPureTechHealthPureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary biotech company creating 21stcentury medicines that modulate the adaptive human systems. Our therapies target the immune,nervous,andgastro-intestinalsystemsbyaddressingtheunderlyingpathophysiologyofdiseasefromasystemsperspectiveratherthanthroughasinglereceptororpathway.Weareadvancingmorethan20clinical studies across our pipeline, with five human proof-of-concept studies andmultiple pivotal orregistration studies expected to read out in the next two years. PureTech Health’s rich and growingresearchanddevelopmentpipelinehasbeendevelopedincollaborationwithsomeoftheworld’sleadingscientific experts, who along with PureTech's experienced team and board analyze more than 650scientificdiscoveriesperyeartoidentifyandadvancetheopportunitieswebelieveholdthemostpromiseforpatients.ThisprocessplacesPureTechHealthon thecuttingedgeofground-breaking scienceandtechnological innovation and leads the Company between and beyond existing disciplines. For moreinformation,visitwww.puretechhealth.comorconnectwithusonTwitter.

ForwardLookingStatement This press release contains statements that are or may be forward-looking statements, includingstatements that relate to thecompany's futureprospects,developmentsandstrategies.The forward-lookingstatementsarebasedoncurrentexpectationsandaresubjecttoknownandunknownrisksanduncertainties that couldcauseactual results,performanceandachievements todiffermaterially fromcurrent expectations, including, but not limited to, those risks and uncertainties described in the riskfactors included in the company's regulatory filings. These forward-looking statements are based onassumptionsregardingthepresentandfuturebusinessstrategiesofthecompanyandtheenvironmentinwhichitwilloperateinthefuture.Eachforward-lookingstatementspeaksonlyasatthedateofthispressrelease.Exceptasrequiredbylaw,regulatoryrequirement,theListingRulesandtheDisclosureandTransparencyRules,neitherthecompanynoranyotherpartyintendstoupdateorrevisetheseforward-lookingstatements,whetherasaresultofnewinformation,futureeventsorotherwise.

###

Contact:

PureTech

AllisonMeadDirector,CommunicationsandInvestorRelations+16176513156amead@puretechhealth.com